SCHEMBL4685289

SCHEMBL4685289

COC(=O)c1cccc(CCC2CC2)c1

nearest known ligand 0.66

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 3/20 0.66
CYP4A11 Q02928 3/20 0.66
LOXL2 Q9Y4K0 1/20 0.59
PPM1D O15297 2/20 0.56
SLC7A5 Q01650 1/20 0.51
MRGPRX4 Q96LA9 2/20 0.50
PARP1 P09874 1/20 0.48
ALDH1A1 P00352 2/20 0.48
HPGD P15428 1/20 0.48
KDM4E B2RXH2 1/20 0.47
MAPT P10636 1/20 0.47
RAB9A P51151 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
MAP1LC3B Q9GZQ8 1/20 0.47
MAP1LC3A Q9H492 1/20 0.47
PTPRB P23467 1/20 0.46
HIF1A Q16665 1/20 0.46
TSHR P16473 1/20 0.45
FOLH1 Q04609 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5264931 0.87 CYP4F2 (0.54) CYP4F2CYP4A11LOXL2PPM1DSLC7A5
SCHEMBL23642786 0.86 CYP4F2 (0.63) CYP4F2CYP4A11LOXL2PPM1DSLC7A5
SCHEMBL2197290 0.85 CYP4F2 (0.61) CYP4F2CYP4A11LOXL2PPM1DSLC7A5
SCHEMBL757429 0.85 LOXL2 (0.62) CYP4F2CYP4A11LOXL2PPM1DSLC7A5
SCHEMBL70173 0.84 CYP4F2 (0.83) CYP4F2CYP4A11LOXL2SLC7A5MRGPRX4
SCHEMBL1532753 0.83 KDM4E (0.55) CYP4F2CYP4A11LOXL2PPM1DKDM4E
SCHEMBL27722715 0.83 CYP4F2 (0.50) CYP4F2CYP4A11PPM1D
SCHEMBL28284087 0.80 PARP14 (0.51) PARP1MAP1LC3BMAP1LC3A
SCHEMBL17982797 0.80 LOXL2 (0.56) CYP4F2CYP4A11LOXL2PPM1DSLC7A5
SCHEMBL46931 0.80 CYP4A11 (1.00) CYP4F2CYP4A11LOXL2SLC7A5MRGPRX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910364-A2 SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE Merck & Co., Inc. (US) 2008-04-16 EP disclosed
WO-2007011833-A2 SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK & CO., INC. (US) 2007-01-25 WO disclosed